PAK1 Tyrosine Phosphorylation Is Required to Induce Epithelial–Mesenchymal Transition and Radioresistance in Lung Cancer Cells
Authors:
- 30 September 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (19) , 5520-5531
Abstract
The p21-activated Ser/Thr kinase 1 (PAK1) kinase has an essential role in tumorigenesis and cell survival in many cancers, but its regulation is not fully understood. In this study, we showed that in response to irradiation of lung cancer cells, PAK1 was upregulated, tyrosine phosphorylated, and translocated to the nucleus. Tyrosine phosphorylation relied upon JAK2 kinase activity and was essential for PAK1 protein stability and binding to Snail. This radiation-induced JAK2–PAK1–Snail signaling pathway increased epithelial–mesenchymal transition (EMT) by regulating epithelial and mesenchymal cell markers. Notably, JAK2 inhibitors mediated radiosensitization and EMT blockade in a mouse xenograft model of lung cancer. Taken together, our findings offered evidence that JAK2 phosphorylates and stabilizes functions of PAK1 that promote EMT and radioresistance in lung cancer cells, with additional implications for the use of JAK2 inhibitors as radiosensitizers in lung cancer treatment. Cancer Res; 74(19); 5520–31. ©2014 AACR.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- RETRACTED: PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cellsPharmacological Research, 2013
- Investigation of Radiation-induced Transcriptome Profile of Radioresistant Non-small Cell Lung Cancer A549 Cells Using RNA-seqPLOS ONE, 2013
- Phosphorylation of Ribosomal Protein S3 and Antiapoptotic TRAF2 Protein Mediates Radioresistance in Non-small Cell Lung Cancer CellsJournal of Biological Chemistry, 2013
- Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapyCancer Treatment Reviews, 2012
- Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryRadiotherapy and Oncology, 2011
- PIM1-Activated PRAS40 Regulates Radioresistance in Non-small Cell Lung Cancer Cells through Interplay with FOXO3a, 14-3-3 and Protein PhosphatasesRadiation Research, 2011
- PAK signaling in oncogenesisOncogene, 2009
- Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancerThe Lancet Oncology, 2008
- Phase I/II Trial of Sequential Chemoradiotherapy Using a Novel Hypoxic Cell Radiosensitizer, Doranidazole (PR-350), in Patients With Locally Advanced Non–Small-Cell Lung Cancer (WJTOG-0002)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent Growth and Abnormal Organization of Mitotic Spindles in Human Epithelial Breast Cancer CellsJournal of Biological Chemistry, 2000